Colorectal cancer microenvironment: Among nutrition, gut microbiota, inflammation and epigenetics

Paolo Garagnani, Chiara Pirazzini, Claudio Franceschi

Research output: Contribution to journalArticle

Abstract

Colorectal cancer (CRC) is a major health problem causing significant morbidity and mortality. During the last decade, results from different studies indicate that the pathogenetic mechanisms of CRC encompass tumour microenvironment, emphasizing a tight correlation with aging, inflammation, nutrition, gut microbiome composition and epigenetic modifications. Aging is one of the most important risk factors for the development of a wide range of neoplasies, including CRC, as it represents the general framework in which the tumor environment evolves. Together, these elements likely contribute to the carcinogenic process with specific effects, impacts and roles in the different stages of the tumor progression. CRCs evolve through loops of deregulated inflammatory stimuli which are sustained by DNA damage signaling pathways, dysbiosis of gut microbiota (GM) and epigenetic re-modelling (DNA methylation). To date no studies address those elements simultaneously. The synergic analysis of such parameters could provide new biological insights and effective biomarkers that could have applications in prevention, molecular diagnosis, prognosis and treatment of CRC.

Original languageEnglish
Pages (from-to)765-778
Number of pages14
JournalCurrent Pharmaceutical Design
Volume19
Issue number4
Publication statusPublished - 2013

Fingerprint

Tumor Microenvironment
Epigenomics
Colorectal Neoplasms
Inflammation
Dysbiosis
DNA Methylation
DNA Damage
Neoplasms
Biomarkers
Morbidity
Mortality
Gastrointestinal Microbiome
Health

Keywords

  • Aging
  • Colorectal cancer
  • Epigenetic
  • Gut microbiota
  • Inflammation
  • Nutrition

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology

Cite this

Colorectal cancer microenvironment : Among nutrition, gut microbiota, inflammation and epigenetics. / Garagnani, Paolo; Pirazzini, Chiara; Franceschi, Claudio.

In: Current Pharmaceutical Design, Vol. 19, No. 4, 2013, p. 765-778.

Research output: Contribution to journalArticle

@article{07ffb1ba332b4b0ebd937ed66b65a22f,
title = "Colorectal cancer microenvironment: Among nutrition, gut microbiota, inflammation and epigenetics",
abstract = "Colorectal cancer (CRC) is a major health problem causing significant morbidity and mortality. During the last decade, results from different studies indicate that the pathogenetic mechanisms of CRC encompass tumour microenvironment, emphasizing a tight correlation with aging, inflammation, nutrition, gut microbiome composition and epigenetic modifications. Aging is one of the most important risk factors for the development of a wide range of neoplasies, including CRC, as it represents the general framework in which the tumor environment evolves. Together, these elements likely contribute to the carcinogenic process with specific effects, impacts and roles in the different stages of the tumor progression. CRCs evolve through loops of deregulated inflammatory stimuli which are sustained by DNA damage signaling pathways, dysbiosis of gut microbiota (GM) and epigenetic re-modelling (DNA methylation). To date no studies address those elements simultaneously. The synergic analysis of such parameters could provide new biological insights and effective biomarkers that could have applications in prevention, molecular diagnosis, prognosis and treatment of CRC.",
keywords = "Aging, Colorectal cancer, Epigenetic, Gut microbiota, Inflammation, Nutrition",
author = "Paolo Garagnani and Chiara Pirazzini and Claudio Franceschi",
year = "2013",
language = "English",
volume = "19",
pages = "765--778",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - Colorectal cancer microenvironment

T2 - Among nutrition, gut microbiota, inflammation and epigenetics

AU - Garagnani, Paolo

AU - Pirazzini, Chiara

AU - Franceschi, Claudio

PY - 2013

Y1 - 2013

N2 - Colorectal cancer (CRC) is a major health problem causing significant morbidity and mortality. During the last decade, results from different studies indicate that the pathogenetic mechanisms of CRC encompass tumour microenvironment, emphasizing a tight correlation with aging, inflammation, nutrition, gut microbiome composition and epigenetic modifications. Aging is one of the most important risk factors for the development of a wide range of neoplasies, including CRC, as it represents the general framework in which the tumor environment evolves. Together, these elements likely contribute to the carcinogenic process with specific effects, impacts and roles in the different stages of the tumor progression. CRCs evolve through loops of deregulated inflammatory stimuli which are sustained by DNA damage signaling pathways, dysbiosis of gut microbiota (GM) and epigenetic re-modelling (DNA methylation). To date no studies address those elements simultaneously. The synergic analysis of such parameters could provide new biological insights and effective biomarkers that could have applications in prevention, molecular diagnosis, prognosis and treatment of CRC.

AB - Colorectal cancer (CRC) is a major health problem causing significant morbidity and mortality. During the last decade, results from different studies indicate that the pathogenetic mechanisms of CRC encompass tumour microenvironment, emphasizing a tight correlation with aging, inflammation, nutrition, gut microbiome composition and epigenetic modifications. Aging is one of the most important risk factors for the development of a wide range of neoplasies, including CRC, as it represents the general framework in which the tumor environment evolves. Together, these elements likely contribute to the carcinogenic process with specific effects, impacts and roles in the different stages of the tumor progression. CRCs evolve through loops of deregulated inflammatory stimuli which are sustained by DNA damage signaling pathways, dysbiosis of gut microbiota (GM) and epigenetic re-modelling (DNA methylation). To date no studies address those elements simultaneously. The synergic analysis of such parameters could provide new biological insights and effective biomarkers that could have applications in prevention, molecular diagnosis, prognosis and treatment of CRC.

KW - Aging

KW - Colorectal cancer

KW - Epigenetic

KW - Gut microbiota

KW - Inflammation

KW - Nutrition

UR - http://www.scopus.com/inward/record.url?scp=84876742643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876742643&partnerID=8YFLogxK

M3 - Article

C2 - 23016865

AN - SCOPUS:84876742643

VL - 19

SP - 765

EP - 778

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 4

ER -